保存先:
| 第一著者: | Tripdatabase |
|---|---|
| フォーマット: | Recurso digital |
| 言語: | |
| 出版事項: |
Zenodo
2026
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.5281/zenodo.20330102 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
類似資料
What are the clinical benefits and potential disadvantages of switching from fedratinib to momelotinib in the management of myelofibrosis?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What is the recommended dose adjustment for doxorubicin in patients on RCHOP who are stable on fluoxetine?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What is neuroleptic malignant syndrome?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What is the recommended protocol for switching a patient from olanzapine to aripiprazole?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What drugs are most effective for reducing agitation in hospital patients?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What are the best practices for administering Cytarabine in a community setting?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
healthbook TIMES. Oncology Hematology
出版事項: (2022)
出版事項: (2022)
What is the recommended management approach for a patient diagnosed with drug-induced uveitis, including specific therapies and cessation of the offending drug?
著者:: Tripdatabase
出版事項: (2025)
著者:: Tripdatabase
出版事項: (2025)
Cancer Survivorship Research & Care
出版事項: (2024)
出版事項: (2024)
What impact does diarrhea from systemic anticancer therapy have on adult oncology patients?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
How can alopecia associated with valproic acid use be managed?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
Adverse drug reactions in internal medicine units at a university hospital: A descriptive pilot study
著者:: LUIS CARLOS LÓPEZ
出版事項: (2010)
著者:: LUIS CARLOS LÓPEZ
出版事項: (2010)
What are the benefits and risks of using azathioprine in oncology patients?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
How well are the effects of liraglutide on cardiovascular events for patients without diabetes documented?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What is the recommended protocol for administering rituximab in patients with rheumatoid arthritis?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What are the risk factors for developing lymphoma or other malignancies in people with Sjögren's Disease, and when should this be suspected and screened for?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
Oncología
出版事項: (2022)
出版事項: (2022)
What are the guidelines for albumin replacement after malignant ascites drainage?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
In a patient with a prior history of Stevens-Johnson syndrome (SJS) induced by sertraline, what is the risk of developing SJS with venlafaxine?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What is the impact of bosutinib on male fertility?
著者:: Tripdatabase
出版事項: (2025)
著者:: Tripdatabase
出版事項: (2025)
Blood Neoplasia
出版事項: (2024)
出版事項: (2024)
What are the common psychosocial barriers leading to non-attendance in psycho-oncology patients?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What are the most effective pharmacological treatments for managing agitation in patients with dementia?
著者:: Tripdatabase
出版事項: (2025)
著者:: Tripdatabase
出版事項: (2025)
Journal of Transition Medicine
出版事項: (2021)
出版事項: (2021)
Targeting Oncogenic Drivers and Signaling Pathways in Hematologic Malignancies
出版事項: (2023)
出版事項: (2023)
MANAGING HYPERCALCEMIA OF MALIGNANCY: EVALUATING CALCITONIN DOSAGE AND EFFICACY
著者:: Siddiqui, Ayesha Rahman
出版事項: (2025)
著者:: Siddiqui, Ayesha Rahman
出版事項: (2025)
Blood Cancer Journal
出版事項: (2012)
出版事項: (2012)
What are the efficacy and safety profiles of topical lidocaine, prilocaine, and tetracaine in pediatric patients?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What are the potential side effects and necessary monitoring for patients on hydroxyurea therapy for sickle cell disease?
著者:: Tripdatabase
出版事項: (2025)
著者:: Tripdatabase
出版事項: (2025)
Leukemia Research Reports
出版事項: (2015)
出版事項: (2015)
Is there evidence that anakinra is suitable for managing pain in patients with pericarditis?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What is the role of aminophylline in patients with congestive heart failure who are also receiving diuretic therapy?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
HAEMATOLOGY/ONCOLOGY ICU OUTCOMES AT THE CANBERRA HOSPITAL: A RETROSPECTIVE COHORT STUDY
著者:: Reynolds, Samuel Mark
出版事項: (2025)
著者:: Reynolds, Samuel Mark
出版事項: (2025)
How can postoperative paresthesia be effectively managed or treated in patients following surgery?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
What are the most effective medications for treating chronic fatigue syndrome?
著者:: Tripdatabase
出版事項: (2025)
著者:: Tripdatabase
出版事項: (2025)
Libri Oncologici
出版事項: (2020)
出版事項: (2020)
Are there clinical trials investigating B. subtilis probiotics for lowering blood pressure in hypertensive patients?
著者:: Tripdatabase
出版事項: (2025)
著者:: Tripdatabase
出版事項: (2025)
For a patient with B12 deficiency on Mounjaro 7.5mg and maximum dose Metformin, with an HbA1c of 43, which medication should be reduced?
著者:: Tripdatabase
出版事項: (2026)
著者:: Tripdatabase
出版事項: (2026)
How do acute oncology services in hospitals impact patient outcomes during cancer-related emergencies?
著者:: Tripdatabase
出版事項: (2025)
著者:: Tripdatabase
出版事項: (2025)
Microbiotherapy and fecal microbiota transplantation in hematology-oncology: a European clinical perspective to navigate the evolving regulatory framework and the emergence of a new therapeutic class.
著者:: Malard F, 等
出版事項: (2026)
著者:: Malard F, 等
出版事項: (2026)
類似資料
-
What are the clinical benefits and potential disadvantages of switching from fedratinib to momelotinib in the management of myelofibrosis?
著者:: Tripdatabase
出版事項: (2026) -
What is the recommended dose adjustment for doxorubicin in patients on RCHOP who are stable on fluoxetine?
著者:: Tripdatabase
出版事項: (2026) -
What is neuroleptic malignant syndrome?
著者:: Tripdatabase
出版事項: (2026) -
What is the recommended protocol for switching a patient from olanzapine to aripiprazole?
著者:: Tripdatabase
出版事項: (2026) -
What drugs are most effective for reducing agitation in hospital patients?
著者:: Tripdatabase
出版事項: (2026)